title: Carlson/FDA - Clostridium difficile 630 - 15k
status: Public on Jan 14 2018
contact.city: Silver Spring
contact.first: Paul
contact.last: Carlson
contact.email: paul.carlson@fda.hhs.gov
contact.state: MD
contact.address: 10903 New Hampshire Ave
contact.department: DBPAP
contact.country: USA
contact.institute: Food and Drug Administration
organism: Clostridioides difficile
description: Agilent-039508
manufacture_protocol: All protocols followed manufacturer's instructions for agilent prokaryotic cRNA kit.  Scanning was performed on an Agilent scanner